Skip to search formSkip to main contentSkip to account menu

SRI-5

Known as: SRI 5 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background and Aims SRI is a composite endpoint used in many SLE trials. The current investigation sought to identify those SRI… 
2016
2016
BAFF/BLyS, a pivotal cytokine in B-cell development, survival and proliferation,1 became a trusted target in systemic lupus… 
Highly Cited
2015
Highly Cited
2015
Objective To evaluate the efficacy and safety of subcutaneous blisibimod, an inhibitor of B cell activating factor, in patients… 
2015
2015
Background RNA gene expression profiling was performed on 1,760 SLE patients randomly selected from Illuminate Trials 1 & 2 which…